Number of Anesthesiology Residents Applying to Pain Medicine Fellowships Decreasing
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Feb. 5, 2025 -- The number of anesthesiology residents applying to pain medicine decreased 45 percent from 2019 to 2023, according to a study published in the January issue of PAIN Practice.
Scott G. Pritzlaff, M.D., from the University of California-Davis in Sacramento, and colleagues examined trends in fellowship applications to pain medicine programs using data from the Electronic Residency Application Service and the National Resident Matching Program from 2019 to 2023. Preliminary data were also examined from the 2024 match cycle.
The researchers found a decrease in anesthesiology residents applying to pain medicine fellowships, from 351 applications in 2019 to 193 in 2023. There was a 45 percent decline in anesthesia-based applicants to pain medicine fellowships, indicating the highest detriment among anesthesiology applicants relative to other specialties. Gender disparities were prevalent, with a decrease in the absolute number of female applicants every year since 2019. The 2023 match saw a significant number of unfilled programs; of 115 programs, 35 failed to fill all positions. This downward trend seems to be continuing based on preliminary data from 2024.
"Addressing the challenges of declining fellowship applicants requires collaborative efforts from program directors and medical educators," the authors write. "By fostering a deeper understanding of career preferences and market dynamics, the field of pain medicine can navigate these changes and ensure a robust workforce equipped to meet society's evolving health care needs."
One author disclosed ties to the pharmaceutical and publishing industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
AAOS: Stopping GLP-1 RAs 14 Days Before Surgery Can Minimize Complications
TUESDAY, March 11, 2025 -- Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize risks for complications...
No Link Seen Between Preop GLP-1 Receptor Agonist Use and Postop Aspiration Pneumonia
THURSDAY, March 6, 2025 -- Preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is not associated with short-term postoperative aspiration pneumonia, according to...
Exercise Beneficial to Mental Health of Women With Chronic Pelvic Pain
TUESDAY, March 4, 2025 -- Engaging in physical activity seems to be beneficial to the mental health of women with chronic pelvic pain disorders (CPPD), according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.